Recent Finacing
Recent Raise
FYR Bio develops AI-enabled, blood-based biomarker tests that enrich disease-derived extracellular vesicles to improve precision medicine in oncology and neuroscience.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at FYR Bio.
